🏢 官网IROPKCodex · 实盘不做把握 9/10
北京时间·🕒 发布 00:30:00时区推断·⟳ 抓取 00:32:54·⚡ 决策 07-24 00:33:32 +38s·95.8 天前
OPKO Health宣布将于7月27日披露二季度业绩并召开电话会
本次只是公司官方披露财报发布时间和电话会安排，未包含业绩数据、指引变化、产品进展或交易对手信息。
📄 原文OPK↗ 原文
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
July 23, 2026 12:30pm EDT Download as PDF MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OP…
不做 OPKO Health（OPK.US）
仅为二季度业绩披露和电话会日程公告，没有业绩数据、指引变化或业务进展，方向不明且无可交易edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-23 · 扩散 low · price-in 风险 low ↗
关键理由
- 本次只是公司官方披露财报发布时间和电话会安排，未包含业绩数据、指引变化、产品进展或交易对手信息。
主要风险
- 真正可交易信息需等7月27日二季度业绩、业务更新和财务指引披露后再评估。
原文全文
展开原文 · 1,917 字
OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026
July 23, 2026 12:30pm EDT
Download as PDF
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) --
OPKO Health, Inc.
(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this
link
. Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations
here
.
A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit
www.opko.com
Contacts:
Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com
Source: OPKO Health, Inc.
Released July 23, 2026
July 23, 2026 12:30pm EDT
Download as PDF
MIAMI, July 23, 2026 (GLOBE NEWSWIRE) --
OPKO Health, Inc.
(OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this
link
. Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations
here
.
A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit
www.opko.com
Contacts:
Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com
Source: OPKO Health, Inc.
Released July 23, 2026
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。